Your account is not claimed yet. You can sign up with ORCID to claim your account.

Chen-Hua Liu (C-H Liu)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 24

Top Venues

Alimentary pharmacology & therapeutics

Journal of clinical medicine

Liver international : official journal of the International Association for the Study of the Liver

Scientific reports

National Taiwan University Hospital

National Taiwan University College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Taiwan University Hospital Jul 1o 2004

Taiwan

visiting staff :: Internal Medicine

Education History

National Taiwan University College of Medicine Sep 1o 2006 - Jul 1o 2015

Taiwan

PHD :: Graduate Institute of Clinical Medicine

Publications

Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of clinical medicine 12 (5) (2023)
Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of clinical medicine 12 (5) (2023)
Chen-Hua Liu
Editorial: Noninvasive tests for metabolic dysfunction-associated steatotic liver disease: A refinement of the Nash-FibroTest for type 2 diabetes mellitus. Alimentary pharmacology & therapeutics 58 (10) (2023)
Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of clinical medicine 12 (5) (2023)
Yen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, Pin-Nan Cheng, Ching-Chu Lo, Lein-Ray Mo, Chun-Ting Chen, Chung-Feng Huang, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Ming-Lun Yeh, Chih-Lang Lin, Yung-Chang Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Han-Chieh Lin, Chi-Yi Chen, Kuo-Chih Tseng, Ming-Lung Yu, null On Behalf Of Tacr Investigators
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals. Viruses 14 (2) (2022)
Chen-Hua Liu, Hsin-Yun Sun, Cheng-Yuan Peng, Szu-Min Hsieh, Sheng-Shun Yang, Wei-Yu Kao, Yu-Lueng Shih, Chih-Lin Lin, Chun-Jen Liu, Wang-Huei Sheng, Yi-Chun Lo, Wen-Chun Liu, Jo-Hsuan Wu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Chien-Ching Hung, Jia-Horng Kao
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open forum infectious diseases 9 (8) (2022)
Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection. Diagnostics (Basel, Switzerland) 12 (11) (2022)
Chen-Hua Liu, Jia-Horng Kao
Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus Infection. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Chi-Yi Chen, Chung-Feng Huang, Pin-Nan Cheng, Kuo-Chih Tseng, Ching-Chu Lo, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Chien-Hung Chen, Ming-Lun Yeh, Chih-Lang Lin, Yung-Chang Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chun-Ting Chen, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Lein-Ray Mo, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Han-Chieh Lin, Ming-Lung Yu
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Tai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, Chen-Yang Hsu, Chun-Ming Hong, Tung-Hung Su, Cheng-Hsueh Tsai, Chi-Ling Chen, Hung-Chih Yang, Chen-Hua Liu, Hsiu-Hsi Chen, Pei-Jer Chen, Jia-Horng Kao
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load. Alimentary pharmacology & therapeutics 53 (8) (2021)
Chen-Hua Liu, Hsin-Yun Sun, Szu-Min Hsieh, Wen-Chun Liu, Wang-Hui Sheng, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Chien-Ching Hung, Jia-Horng Kao
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy. Journal of viral hepatitis 28 (6) (2021)
Chen-Hua Liu, Cheng-Yuan Peng, Wei-Yu Kao, Sheng-Shun Yang, Yu-Lueng Shih, Chin-Lin Lin, Meng-Kun Tsai, Chih-Yuan Lee, Chun-Chao Chang, Jo-Hsuan Wu, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Jia-Horng Kao
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment. Alimentary pharmacology & therapeutics (2021)
Chen-Hua Liu, Cheng-Yuan Peng, Yu-Jen Fang, Wei-Yu Kao, Sheng-Shun Yang, Cheng-Kuan Lin, Hsueh-Chou Lai, Wen-Pang Su, Sheng-Uei Fang, Chun-Chao Chang, Tung-Hung Su, Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis. Scientific reports 10 (1) (2020)
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Yung-Chang Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Pei-Chien Tsai, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Cheng-Yuan Peng
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis. Scientific reports 10 (1) (2020)
Chen-Hua Liu, Sheng-Shun Yang, Cheng-Yuan Peng, Woan-Tyy Lin, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment. Journal of viral hepatitis 27 (6) (2020)
Chen-Hua Liu, Jia-Horng Kao
Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors' reply. Alimentary pharmacology & therapeutics 50 (1) (2020)
Chen-Hua Liu, Jia-Horng Kao
Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C - authors' reply. Alimentary pharmacology & therapeutics 49 (1) (2019)
Tung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, Shih-Wan Chou, Chen-Hua Liu, Hung-Chih Yang, Shang-Ju Wu, Pei-Jer Chen, Ding-Shinn Chen, Chi-Ling Chen, Jia-Horng Kao
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma. Alimentary pharmacology & therapeutics 49 (5) (2019)
Chen-Hua Liu, Jia-Horng Kao
Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction? Alimentary pharmacology & therapeutics 49 (2) (2019)
Chen-Hua Liu, Yu-Lueng Shih, Sheng-Shun Yang, Chih-Lin Lin, Yu-Jen Fang, Pin-Nan Cheng, Chi-Yi Chen, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yen-Cheng Chiu, Tung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis. Journal of gastroenterology and hepatology 34 (11) (2019)
Chen-Hua Liu, Chun-Jen Liu, Chien-Ching Hung, Szu-Min Hsieh, Tung-Hung Su, Hsin-Yun Sun, Tai-Chung Tseng, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan. Liver international : official journal of the International Association for the Study of the Liver 40 (4) (2019)
Tung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, Shih-Wan Chou, Chen-Hua Liu, Hung-Chih Yang, Shang-Ju Wu, Pei-Jer Chen, Ding-Shinn Chen, Chi-Ling Chen, Jia-Horng Kao
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection. Alimentary pharmacology & therapeutics 49 (3) (2018)
Chen-Hua Liu, H-Y Sun, Chun-Jen Liu, W-H Sheng, S-M Hsieh, Y-C Lo, W-C Liu, T-H Su, H-C Yang, C-M Hong, T-C Tseng, P-J Chen, D-S Chen, Chien-Ching Hung, Jia-Horng Kao
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection. Alimentary pharmacology & therapeutics 47 (12) (2018)
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yi-Hsiang Huang, Wei-Wen Su, Pin-Nan Cheng, Chih-Lin Lin, Ching-Chu Lo, Chi-Yi Chen, Jyh-Jou Chen, Qian Ma, Craig Brooks-Rooney, Jia-Horng Kao
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan. Alimentary pharmacology & therapeutics 48 (11-12) (2018)

Chen-Hua Liu.css-eqlu8i{font-size:small;padding-left:4px;} (C-H Liu)

Publication Activity (10 Years)

Top Topics

Top Venues

Chen-Hua Liu (C-H Liu)